XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS' EQUITY (DEFICIENCY) - Equity-based compensation expense (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based compensation expense          
Share-based compensation expense $ 3,445 $ 264 $ 812 $ 596 $ 546
unrecognized compensation costs $ 18,394   $ 2,280    
Weighted average period of recognition 3 years 4 months 13 days   3 years 3 months 10 days    
Weighted average exercise price of the options granted     $ 9.81 $ 4.42 $ 4.06
Weighted-average grant date fair value of options granted     $ 0.6 $ 0.76 $ 4.45
Research and Development Expense [Member]          
Share-based compensation expense          
Share-based compensation expense $ 2,260 169 $ 654 $ 372 $ 380
Selling and Marketing Expense [Member]          
Share-based compensation expense          
Share-based compensation expense 60 7 7 20 18
General and Administrative Expense [Member]          
Share-based compensation expense          
Share-based compensation expense $ 1,125 $ 88 $ 151 $ 204 $ 148